Staphylococcus aureus skin and soft tissue infections: Can we anticipate the culture result?

Clinical Pediatrics

Volumn 49, Issue 5, 2010, Pages 432-438

  Bar Meir, Maskit ^a   Tan, Tina Q ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Methicillin resistant Staphylococcus aureus; Methicillin susceptible Staphylococcus aureus; Staphylococcal skin infections

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEGRO; NOSE; PREDICTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; RACE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; SOFT TISSUE INFECTION; TRUNK;

AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; BLOOD; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MULTIVARIATE ANALYSIS; NOSE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77952969365     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922809350496     Document Type: Article

References (26)

1. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005; 40: 1785-1791.
2. Sattler CA, Mason EO Jr, Kaplan SL Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002; 21: 910-917.
3. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998; 279: 593-598.
4. Fergie JE, Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children. Pediatr Infect Dis J. 2001; 20: 860-863.
5. Labandeira-Rey M., Couzon F., Boisset S., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007; 315: 1130-1133. (Pubitemid 46328024)
6. Gonzalez BE, Martinez-Aguilar G., Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005; 115: 642-648.
7. Crum NF The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis. 2005; 37: 651-656.
8. Davis SL, Perri MB, Donabedian SM, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol. 2007; 45: 1705-1711.
9. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003; 41: 5113-5120.
10. Weber JT Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005; 41 (suppl 4). S269-S272.
11. Miller LG, Perdreau-Remington F., Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation. Clin Infect Dis. 2007; 44: 471-482.
12. Creech CB 2nd, Kernodle DS, Alsentzer A., Wilson C., Edwards KM Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005; 24: 617-621.
13. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004; 39: 971-979.
14. von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001; 344: 11-16. (Pubitemid 32064839)
15. Wertheim HF, Vos MC, Ott A., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004; 364: 703-705.
16. Centers for Disease Control and Prevention. Community-associated MRSA information for clinicians. http://www.cdc.gov/ncidod/dhqp/ar-mrsa-ca- clinicians.html. Accessed September 19, 2009.
17. National Committee on Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing. 9th Informational Supplement. Wayne, PA: NCCLS; 1999.
18. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995; 33: 2233-2239.
19. Lina G., Piemont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999; 29: 1128-1132.
20. Deeks JJ, Altman DG Diagnostic tests 4: likelihood ratios. BMJ. 2004; 329: 168-169.
21. Altman DG, Bland JM Diagnostic tests 2: predictive values. BMJ. 1994; 309: 102.
22. Goodman SN Toward evidence-based medical statistics. 2: the Bayes factor. Ann Intern Med. 1999; 130: 1005-1013.
23. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004; 139: 947-951.
24. Fridkin SK, Hageman JC, Morrison M., et al. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005; 352: 1436-1444.
25. Naimi TS, LeDell KH, Como-Sabetti K., et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureusinfection. JAMA. 2003; 290: 2976-2984.
26. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006; 144: 309-317.